SPP1 and atherosclerosis: Single-cell and spatial analyses revealed a significant interaction between SPP1+ macrophages and ITLN1+ foam cells, mediated by the SPP1-CD44 ligand-receptor axes, which accelerates arterial lipid accumulation and EMT transformation, which is necessary to develop effective immunotherapeutic strategies against atherosclerosis (AS) (45).